Navigation Links
UCLA study assesses cost-effectiveness of Hepatitis B drugs

-- which require different treatment approaches.

Hepatitis B is the most common serious liver infection in the world. The virus attacks liver cells and chronic hepatitis B disease can lead to liver failure, cirrhosis or cancer of the liver. About 90 percent of healthy adults who are infected with Hepatitis B recover with no problems, but 10 percent develop chronic disease. In children who have been infected, 60 percent develop chronic disease.

Other authors include Dr. Ian M. Gralnek, MSHS, Dr. Gareth S. Dulai, MSHS, and Mary Farid, Division of Gastroenterology, VA Greater Los Angeles HealthCare System and Division of Digestive Diseases, David Geffen School of Medicine at UCLA, Center for the Study of Digestive Healthcare Quality and Outcomes, Los Angeles, California; and Dr. Paul Martin, Mount Sinai School of Medicine, New York, New York.


'"/>

Source:University of California - Los Angeles


Page: 1 2 3

Related biology news :

1. Bioartificial kidney under study at MCG
2. W.M. Keck Foundation funds study of friendly microbes
3. Yellowstone microbes fueled by hydrogen, according to U. of Colorado study
4. Genome-wide mouse study yields link to human leukemia
5. Clam embryo study shows pollutant mixture adversely affects nerve cell development
6. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
7. Same mutation aided evolution in many fish species, Stanford study finds
8. Sequencing of marine bacterium will help study of cell communication
9. Genetically modified rice in China benefits farmers health, study finds
10. A new study examines how shared pathogens affect host populations
11. NYU study reveals how brains immune system fights viral encephalitis
Post Your Comments:
(Date:7/23/2008)...lands published online in The FASEB Journal ( ht...an saliva that greatly speeds wound healing. This ...hronic wounds related to diabetes and other disord...ddition, because the compounds can be mass produce...antibiotic creams and rubbing alcohol. , "We hop...
(Date:7/23/2008)...rom the lower abdomen and inner thigh through lipo...m cells, with higher stem cell concentrations than...d study in August,s Plastic and Reconstructive Su...an Society of Plastic Surgeons (ASPS). This is the...ssues from different areas of the body vary in ste...
(Date:7/23/2008)... Dan Shain is redefining the term "summer action h...y Amazon planned, all in the name of scientific re...ociate professor of biology at RutgersCamden, trav...nges, and returns home with treasure. He,s mined ...ood in leech-infested tropical waters; and studied...
(Date:7/23/2008)...include confirmation that East Java,s "Lusi" mud v...he Banjar Panji-1 well; evidence of the oldest hum...Nile delta; analysis of Yellowstone,s hotspot; and...es occur in the Snake River Plain. GSA Today ,s s...am in Grand Canyon on sandbar ecosystems along the...
Breaking Biology News(10 mins):Licking your wounds: Scientists isolate compound in human saliva that speeds wound healing 2Want a reason to love your lower belly fat? It's rich in stem cells 2Rutgers biologist to study worms in Amazon, glaciers 2August 2008 Geology and GSA Today media highlights 2August 2008 Geology and GSA Today media highlights 3August 2008 Geology and GSA Today media highlights 4August 2008 Geology and GSA Today media highlights 5August 2008 Geology and GSA Today media highlights 6August 2008 Geology and GSA Today media highlights 7August 2008 Geology and GSA Today media highlights 8August 2008 Geology and GSA Today media highlights 9August 2008 Geology and GSA Today media highlights 10August 2008 Geology and GSA Today media highlights 11August 2008 Geology and GSA Today media highlights 12CASTLE Study Showed Similar Efficacy Between Once Daily REYATAZ 28R 29 28atazanavir sulfate 29 ritonavir and Twice Daily lopinavir ritonavir at 48 We 1334 1CASTLE Study Showed Similar Efficacy Between Once Daily REYATAZ 28R 29 28atazanavir sulfate 29 ritonavir and Twice Daily lopinavir ritonavir at 48 We 1334 2CASTLE Study Showed Similar Efficacy Between Once Daily REYATAZ 28R 29 28atazanavir sulfate 29 ritonavir and Twice Daily lopinavir ritonavir at 48 We 1334 3CASTLE Study Showed Similar Efficacy Between Once Daily REYATAZ 28R 29 28atazanavir sulfate 29 ritonavir and Twice Daily lopinavir ritonavir at 48 We 1334 4CASTLE Study Showed Similar Efficacy Between Once Daily REYATAZ 28R 29 28atazanavir sulfate 29 ritonavir and Twice Daily lopinavir ritonavir at 48 We 1334 5CASTLE Study Showed Similar Efficacy Between Once Daily REYATAZ 28R 29 28atazanavir sulfate 29 ritonavir and Twice Daily lopinavir ritonavir at 48 We 1334 6Vicriviroc Demonstrates Potent and Sustained Viral Suppression Through 48 Weeks of Therapy in Treatment Experienced HIV Infected Patients 11226 1Vicriviroc Demonstrates Potent and Sustained Viral Suppression Through 48 Weeks of Therapy in Treatment Experienced HIV Infected Patients 11226 2Vicriviroc Demonstrates Potent and Sustained Viral Suppression Through 48 Weeks of Therapy in Treatment Experienced HIV Infected Patients 11226 3Vicriviroc Demonstrates Potent and Sustained Viral Suppression Through 48 Weeks of Therapy in Treatment Experienced HIV Infected Patients 11226 4VIRxSYS Announces Interim Results from VRX496 Gene Therapy Phase II Trial 3091 1VIRxSYS Announces Interim Results from VRX496 Gene Therapy Phase II Trial 3091 2Gene plays Jekyll and Hyde in brain cancer 11223 1Gene plays Jekyll and Hyde in brain cancer 11223 2Gene plays Jekyll and Hyde in brain cancer 11223 3
...aunting task to find a smoking gun for Darwinian e...t just when and how a specific gene mutated but al...l-world dominance of one population over another. ...xperiment that forced bacteria to compete in a hea...y offer the first glimpse of how individual geneti...
...ch Hospital have announced that a vaccine they dev...nt of the avian influenza virus H5N1 may protect h...es based on this model might therefore be suitable...ide epidemic) until a new vaccine could be develop...tbreak, the researchers said. An antigen is a mole...
...rugs, which prevent genes from producing harmful p...promise to be more effective than conventional dru... has been slow. , Using gold nanoparticles combine...now have demonstrated a new method for developing ...ense agents. The findings will be published May 19...
...ch Hospital have announced that a vaccine they dev...nt of the avian influenza virus H5N1 may protect h...es based on this model might therefore be suitable...ide epidemic) until a new vaccine could be develop...tbreak, the researchers said. An antigen is a mole...
Other Biology News:Ready, set, mutate?and may the best microbe win 2Ready, set, mutate?and may the best microbe win 3Scientists to employ Arctic ice and polar bears to protect diversity of world's crops 2Gold nanoparticles could improve antisense cancer drugs 2H5N1 vaccine could be basis for life-saving stockpile 2
(Date:7/24/2008)...re/ -- The Global Probiotics Council,(GPC), a comm...ult Honsha,Co., Ltd., announced the two awardees w...rant for Probiotics Research (YIGPRO) today. The p...who will continue to contribute to,the advancement...United,States., Ajay S. Gulati, MD, an Assistant ...
(Date:7/24/2008)... Important Advance in Radiofrequency ...if., July 24 /- PEAK Surgical, Inc., ...tissue dissection system,based on a proprietary te...rug Administration has granted the company 510(k) ... use in general surgery. The PEAK Surgery System,c...
(Date:7/24/2008)...ire/ -- Sagent Pharmaceuticals, Inc.,a privately-...nced that it,has launched ceftazidime for injectio...m antibiotic. Sagent will offer ceftazidime in 1,a...ge vials. According to,IMS data, 2007 sales of inj...ximately $45.7 million., "Sagent is proud to be p...
(Date:7/24/2008)...swire-FirstCall/ -- United,Therapeutics Corporatio...lease its 2008 second quarter financial results be...., United Therapeutics will host a half-hour tele.... Eastern Time. The teleconference is accessible,b...rs dialing,1-706-679-8129. A rebroadcast of the te...
Breaking Biology Technology:Global Probiotics Council Announces First Awardees for New Young Investigator Grant for Probiotics Research 2Global Probiotics Council Announces First Awardees for New Young Investigator Grant for Probiotics Research 3Global Probiotics Council Announces First Awardees for New Young Investigator Grant for Probiotics Research 4PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in General Surgery 2PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in General Surgery 3PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in General Surgery 4Sagent Pharmaceuticals Launches Ceftazidime for Injection, USP 2
...segment of a national and international pipeline t...announcement that CellCura, Inc. , a Norwegian bi...e opening a location in Madison,s University Rese...any to start or locate in Wisconsin during the pas...nal search and will open in Madison with a small t...
...t two Google products do not infringe on patents...ted a motion to dismiss a lawsuit brought against ...udge John Shabaz has ruled that Google,s AdSense ...nts held by the Madison-based HyperPhrase Technolo...e patents, which pertain to a technology that crea...
...ppear to have too many worries right now. As the C...ies that dominates classified advertising, he lead...orldwide. And since the dismissal of a housing dis...icago, the organization could have one less contro...n much of the credit for designing the company,s m...
...n leaves behind an economic year in which some new...off, and the state,s tech economy positioned itsel...k, 2007 should be even better, but the investment ...ed to turn a cold shoulder to ideas that would hur...ketplace. What,s in store for the New Year? Severa...
Other Biology Technology:CellCura could start an invasion of stem cell firms 2CellCura could start an invasion of stem cell firms 3Wisconsin judge dismisses patent suit vs. Google 2Craigslist exec strives to keep the Internet neutral 2Craigslist exec strives to keep the Internet neutral 3Craigslist exec strives to keep the Internet neutral 4Wisconsin's high-growth economy: '07 predictions 2Wisconsin's high-growth economy: '07 predictions 3Wisconsin's high-growth economy: '07 predictions 4
Physical form: Essentially sulfate-free, powder containing carbohydrate and citrate buffer salts Preparation Unit Definition: One unit will convert 1.0 mole of D -fructose 6-phosphate to D -gluco
S-Protein Agarose from Novagen
Packaging: 6 bottles for 1 l ready-to-use-solution ID clarifier: ready-to-use solution
... who function to ensure the integrity of the DNA s...ing the nascent strands in DNA ,replication, in tr... in preventing chromosomal recombination between d...pecifically at base pair mismatches and small (<4 ...
Biology Products: